Several Options for Frontline Treatment of MCL
/ Mats Jerkeman
The 2025 EHA Award Recipients
/ Amanda Feldballe Bernholm
EHA 2025: Nordic AML Group Explores Optimized Regimen for AML Patients
/ Anne Louise Tølbøll Sørensen
EHA 2025: Impact of Treating MRD Relapse Post 1L in Multiple Myeloma
/ Frida Bugge Askeland
High Expression of the Inhibitory Checkpoint Receptor TIGIT by CD8+ T-cells in Multiple Myeloma
/ Katrine Fladeland Iversen